BioMarin Pharma Reports Director Changes and Officer Compensation Updates
Ticker: BMRN · Form: 8-K · Filed: May 22, 2025 · CIK: 1048477
| Field | Detail |
|---|---|
| Company | Biomarin Pharmaceutical INC (BMRN) |
| Form Type | 8-K |
| Filed Date | May 22, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, executive-compensation, board-of-directors
Related Tickers: BMRN
TL;DR
BioMarin's board is shuffling, with director departures and new elections, plus exec pay adjustments.
AI Summary
On May 20, 2025, BioMarin Pharmaceutical Inc. filed an 8-K report detailing changes in its board of directors and executive compensation. The filing indicates a departure of a director and the election of new directors, alongside updates to compensatory arrangements for certain officers. These changes are effective as of May 20, 2025.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: low — The filing primarily concerns routine corporate governance and executive compensation matters, not a material event like a merger or significant financial distress.
Key Players & Entities
- BioMarin Pharmaceutical Inc. (company) — Registrant
- May 20, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 68-0397820 (identifier) — I.R.S. Employer Identification No.
- 770 Lindaro Street San Rafael California 94901 (address) — Principal Executive Offices
- (415) 506-6700 (phone_number) — Registrant's telephone number
FAQ
What specific items are covered in this 8-K filing by BioMarin Pharmaceutical Inc.?
This 8-K filing covers the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers, as well as the submission of matters to a vote of security holders.
What is the date of the earliest event reported in this filing?
The date of the earliest event reported in this filing is May 20, 2025.
In which state is BioMarin Pharmaceutical Inc. incorporated?
BioMarin Pharmaceutical Inc. is incorporated in Delaware.
What is the principal executive office address for BioMarin Pharmaceutical Inc.?
The principal executive office address for BioMarin Pharmaceutical Inc. is 770 Lindaro Street, San Rafael, California, 94901.
What is the telephone number listed for BioMarin Pharmaceutical Inc.?
The telephone number listed for BioMarin Pharmaceutical Inc. is (415) 506-6700.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 22, 2025 regarding BIOMARIN PHARMACEUTICAL INC (BMRN).